Antibody Profiles in Inflammatory and Non-Inflammatory Bullous Pemphigoid

niversity Hospitals of Leicester0 个研究点目标入组 22 人开始时间: 2019年8月27日最近更新: 2020年8月24日

适应症

试验速览

暂无简介。

•1. Willing and able to give informed consent for participation in the study.
•2. Aged 18 years or above.
•3. Clinical diagnosis of suspected bullous pemphigoid.
•4. Direct immunofluorescence on skin biopsy (which is performed as part of usual care) demonstrating linear deposition of IgG and/or C3 at the basement membrane zone reported within 8 weeks of enrolment.
•5. Able (in the Investigators’ opinion) and willing to comply with all study requirements.

•1. Alternative diagnosis to bullous pemphigoid at review by a dermatologist.
•2. Skin biopsy is judged to be contraindicated for clinical reasons by the Investigator.
•3. Direct immunofluorescence of a skin biopsy fails to demonstrate linear deposition of IgG or C3 at the basement membrane zone within 8 weeks of enrolment.

发起方

niversity Hospitals of Leicester